CTOs on the Move

Impact Advisors

www.impact-advisors.com

 
Impact Advisors is a nationally recognized healthcare consulting firm that is solving some of the toughest challenges in the industry by delivering strategic advisory, implementation and optimization services. Our comprehensive suite of patient access, clinical and revenue cycle services span the lifecycle of our clients` needs. Our experienced team has a powerful combination of clinical, revenue, operations, consulting, and IT experience. The firm has earned a number of prestigious industry and workplace awards including Best in KLAS® for thirteen consecutive years, Healthcare Informatics HCI 100, Crain`s Chicago Business Fast Fifty, as well as multi-year “best place to work” awards from: ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Michael Doyle
 Vice President of Information Technology Advisory Enterprise Analytics Profile
Marc Johnson
 Senior Advisor / vCISO / vCIO Profile

Similar Companies

Community Health Center of the North Country

Community Health Center of the North Country is a healthcare provider with locations in St. Lawrence, Franklin, and Jefferson counties in Northern New York. They offer comprehensive primary, pediatric, behavioral, dental, optometry, and preventative ca...

Northwest Pharmacy Svc

Northwest Pharmacy Svc is a Enumclaw, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ION Medical

ION Medical is a Mission Viejo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

LXN Corporation

LXN Corporation is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

FibroGen

FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).